PDF-COPD exacerbations denitions and classications S

Burge JA Wedzicha COPD exacerbations de64257nitions and classi64257cations S Burge JA Wedzicha ERS Journals Ltd 2003 ABSTRACT Chronic obstructive pulmonary disease COPD is de64257ned independently of exacerbations which are largely a feature of mod. What we will cover: . Malnutrition . and COPD. Oral nutrition supplements. Recommended dietary patterns for people with COPD . Bone Health . Obesity. Micronutrient supplements . Katherine Stern . Dietitian 10/10/2014. George G Burton, M.D.*. *From: Depts of Pulmonary Medicine and Respiratory Care. Kettering Medical Center. Dayton, OH 45429. Goals of This Presentation. Transformation of the traditional care environment. Clinical Research Fellow. University of Oxford. Acute Exacerbations of COPD. Introduction . Epidemiology. Causes. How to know who’s exacerbating. When to use antibiotics. When to use corticosteroids. What you should know. !. Todd Tyson, BS, RRT. GAMES Annual Meeting. Jekyll Island. Questions regarding vent . ???. 1. Are you currently accredited to provide ventilators?. 2. Are you Medicare Certified? Does your 855S application include provision for ventilators?. Patient may or may not notice symptoms .. Life expectancy for stage 1 people is only slightly less than the normal people. . It is around 17.4 years for a male who is 65 year old. . Patients who continue smoking will have shorter life than who does not smoke or who stop smoking. . Clinical Trial Evidence. Introduction . Therapeutic Recommendations . Therapeutic Recommendations in Groups B and D . Bronchodilators in Stable COPD. ICS in Stable COPD. COPD . Potential AEs of ICS Treatment. D94- COPD: EPIDEMIOLOGY AND THERAPY. Mini Symposium. Wednesday May 22. Marjan. Kerkhof. 1. , Jaco Voorham. 1. , Claudia Cabrera. 2. , Patrick Darken. 2. , Paul Dorinsky. 2. , . Janwillem. W.H. Kocks. February 2017. RAJAN JOSHI MD,FCCP. ASST. PROFESSOR ,UKMC. LEXINGTON. PULMONARY-CCM-SLEEP SPECIALIST. BHR & MW HOSPITAL . © 2017 Global Initiative for Chronic Obstructive Lung Disease. © 2017 Global Initiative for Chronic Obstructive Lung Disease. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical What is COPD?. How to treat COPD?. What is the prognosis?. 19.3% of US Adults Smoke – 2010. CDC, NHIS 2010. 2010 Current Smokers. %. of Smokers. Demographic. % of Smokers. Demographic. 19.3%. US Adults. *Based on GOLD Risk Stratification 2019. Category. Symptoms. Risk. Suggested Treatment. Co-. Management. ALL Patients. Short-acting Bronchodilator. (rescue). Self-Management. Education. Smoking cessation. disease . is characterized by . . airflow limitation that is not fully . reversible.. The . airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. . Dr Victor Duong. Senior Medical Registrar. Northern Health. Asthma. Overview. Initial assessment and management in the ED. Inpatient management. Preparing for discharge. What is not covered. Diagnostic aspects. 2. , . Petter. Olsson. 3. , . Hungta. Chen. 4. , Robert Fogel. 4. , Donald . Banerji. 4. 1. Airway . Disease Section, National Heart and Lung Institute, Imperial College London, London, UK; . 2. Respiratory Division, University of Leuven, Leuven, Belgium; .